Eversept Partners, LP - AADI BIOSCIENCE INC ownership

AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 73 filers reported holding AADI BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.5%.

Quarter-by-quarter ownership
Eversept Partners, LP ownership history of AADI BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$493,283
-29.2%
101,9180.0%0.04%
-27.6%
Q2 2023$697,119
-5.5%
101,9180.0%0.06%
+13.7%
Q1 2023$737,886
-43.6%
101,9180.0%0.05%
-55.7%
Q4 2022$1,307,608
-9.2%
101,9180.0%0.12%
-8.0%
Q3 2022$1,440,101
+15.9%
101,918
+1.1%
0.12%
+42.0%
Q2 2022$1,242,065
-51.5%
100,817
-33.2%
0.09%
-55.3%
Q1 2022$2,559,364150,8170.20%
Other shareholders
AADI BIOSCIENCE INC shareholders Q3 2023
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 26,666$193,06217.76%
Alerce Investment Management, L.P. 1,630,830$11,807,20915.60%
ACUTA CAPITAL PARTNERS, LLC 1,849,402$13,389,6709.86%
Decheng Capital Management III (Cayman), LLC 526,329$3,810,6221.54%
Knott David M Jr 183,688$1,3300.52%
Vivo Capital, LLC 509,572$6,456,2770.45%
Ghost Tree Capital, LLC 150,000$1,086,0000.32%
Avoro Capital Advisors LLC 2,849,402$20,629,6700.31%
Parkman Healthcare Partners LLC 75,961$549,9580.12%
RA Capital Management 590,218$4,273,1780.10%
View complete list of AADI BIOSCIENCE INC shareholders